Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment
出版年份 2015 全文链接
标题
Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment
作者
关键词
<sup>177</sup>Lu-DOTATATE therapy, PRRT, Neuroendocrine tumours, Dosimetry
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 42, Issue 6, Pages 947-955
出版商
Springer Nature
发表日期
2015-02-05
DOI
10.1007/s00259-015-3001-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2013) A. Sabet et al. JOURNAL OF NUCLEAR MEDICINE
- Kidney Dosimetry in177Lu and90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors
- (2013) F. Guerriero et al. Biomed Research International
- Significant impact of transient deterioration of renal function on dosimetry in PRRT
- (2012) Sofie Van Binnebeek et al. ANNALS OF NUCLEAR MEDICINE
- Renal and Hematological Toxicity in Patients of Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
- (2012) Santosh K. Gupta et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Lutetium-labelled peptides for therapy of neuroendocrine tumours
- (2012) B. L. R. Kam et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- (2012) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Lessons on Tumour Response: Imaging during Therapy with 177Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma
- (2012) Ulrike Garske et al. Theranostics
- Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy
- (2012) Maria Larsson et al. EJNMMI Research
- Minor changes in effective half-life during fractionated177Lu-Octreotate therapy
- (2011) Ulrike Garske et al. ACTA ONCOLOGICA
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
- (2011) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [177Lu-DOTA0,Tyr3]Octreotate
- (2011) S. Khan et al. JOURNAL OF NUCLEAR MEDICINE
- Chronic kidney disease
- (2011) Andrew S Levey et al. LANCET
- 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy
- (2010) Michael Garkavij et al. CANCER
- Inflammation in the pathophysiology of essential hypertension
- (2010) Fabrizio Montecucco et al. JOURNAL OF NEPHROLOGY
- Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
- (2010) Dik J. Kwekkeboom et al. SEMINARS IN NUCLEAR MEDICINE
- Functional Renal Imaging: New Trends in Radiology and Nuclear Medicine
- (2010) Emmanuel Durand et al. SEMINARS IN NUCLEAR MEDICINE
- [177Lu-DOTA0-Tyr3]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed Dose to the Kidney
- (2010) Christina Swärd et al. WORLD JOURNAL OF SURGERY
- Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
- (2009) Flavio Forrer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate
- (2009) Mattias Sandström et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake
- (2009) Bin He et al. MEDICAL PHYSICS
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
- (2008) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now